FET reports gains in sales of meltspinning lines to biomedical sector
LEEDS, UK, September 13, 2021-
Fibre Extrusion Technology of Leeds, UK has now delivered nine meltspinning systems to clients in the biomedical sector since the onset of the Covid-19 pandemic, with a similar number currently on order for 2021/22. This confirms FET’s position as an acknowledged world leader in meltspinning equipment for the production of precursor materials used in medical devices and the default supplier for absorbable suture production systems, with orders virtually doubling year on year.
Managing Director Richard Slack emphasised the long term planning and execution that has contributed to success in this industry. “FET has a long tradition in the highly regulated biomedical sector and we believe our experience is unrivalled. We have built a world leading reputation for melt spinning medical grade polymers in both synthetic resorbable and non-absorbable polymers and FET is now reaping the rewards of this initiative”.
Not a subscriber?